Biotechnology Stocks II Performance Guide: Allogene Therapeutics, Inc. (ALLO)
ALLO has no dividends.
Table and Chart of ALLO Performance
See what a $1,000 investment in ALLO is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| ALLO Returns | |
|---|---|
| Start Date | Nov-30-2018 |
| Start Price | $31.28 |
| End Date | Jul-26-2024 |
| End Price | $3.00 |
| # Prices | 69 |
| Min Date | Jun-28-2024 |
| Min Price | $2.33 |
| Max Date | May-29-2020 |
| Max Price | $48.16 |
| Total Return | -90.41% |
| Annualized Return | -33.48% |
| Current Value of $1,000 Purchase | $96 |
| Number Returns | 2,346 |
| Average Return | -46.46% |
| Number Profitable Returns | 337 |
| Percent Profitable Returns | 14.36% |
| Number Unprofitable Returns | 2,009 |
| Percent Unprofitable Returns | 85.64% |
| Profitable to Unprofitable Returns Ratio | 0.17 |
| ALLO Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $607,561,000 |
| Beta | 0.851 | Price to Sales | 6,763.68 |
| Earnings per Share | $-1.7800 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 1.254 |
| PRICE DATA | |
| 52 Week High | $5.78 |
| 52 Week Low | $2.01 |
| Analyst Target Price | $11.51 |
| 50-Day Moving Average | $2.583 |
| 200-Day Moving Average | $3.261 |
| FINANCIAL DATA | |
| Revenue per Share | $0.001 |
| Revenue | $87,000 |
| Profit Margin | 0% |
| Return on Equity | -55.5% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
ALLO Compare Returns with S&P 500
ALLO Trendline Chart
ALLO Moving Average Chart
ALLO Stock Return Map - See Patterns of Gains and Losses
ALLO Stock Returns/Purchase Dates